Brain structural changes and their correlation with vascular disease in type 2 diabetes mellitus patients: A voxel-based morphometric study

Neural Regeneration Research

Volumn 9, Issue 16, 2014, Pages 1548-1556

  Wang, Chun Xia ^a   Fu, Kai Liang ^a   Liu, Huai Jun ^a   Xing, Fei ^a   Zhang, Song Yun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Albuminuria; Ankle brachial index; Diabetes mellitus; Nerve regeneration; Neural Regeneration

Indexed keywords

ALBUMIN; C PEPTIDE; CREATININE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE; BODY MASS; BRAIN; BRAIN CORTEX ATROPHY; BRAIN SIZE; BRAIN STRUCTURE; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EXPERIMENTAL COGNITIVE TEST; FEMALE; GLUCOSE BLOOD LEVEL; GRAY MATTER; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN SENSITIVITY; MALE; MICROALBUMINURIA; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PERIPHERAL OCCLUSIVE ARTERY DISEASE; VASCULAR DISEASE; VASCULAR LESION; VOXEL BASED MORPHOMETRY; WHITE MATTER;

EID: 84907142518     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.139482     Document Type: Article

References (44)

1. Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, Tanaka S, Ohashi Y, Iguchi A, Yokono K, Ito H (2006) Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 22:376-384.
2. Alagiakrishnan K, Zhao N, Mereu L, Senior P, Senthilselvan A (2013) Montreal Cognitive Assessment is superior to Standardized Mini-Mental Status Exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. BioMed Res Int 2013:186106.
3. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553.
4. Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38:95-113.
5. Ashburner J, Friston KJ (2000) Voxel-based morphometry--the methods. Neuroimage 11:805-821.
6. Baumgartner I, Schainfeld R, Graziani L (2005) Management of peripheral vascular disease. Annu Rev Med 56:249-272.
7. Biessels GJ, Deary IJ, Ryan CM (2008) Cognition and diabetes: a lifespan perspective. Lancet Neurol 7:184-190.
8. Bruehl H, Sweat V, Tirsi A, Shah B, Convit A (2011) Obese adolescents with type 2 diabetes mellitus have hippocampal and frontal lobe volume reductions. Neurosci Med 2:34-42.
9. Bruehl H, Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A (2009) Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res 1280:186-194.
10. Carmichael OT, Kuller LH, Lopez OL, Thompson PM, Dutton RA, Lu A, Lee SE, Lee JY, Aizenstein HJ, Meltzer CC, Liu Y, Toga AW, Becker JT (2007) Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis Assoc Disord 21:14-24.
11. Chen Z, Li L, Sun J, Ma L (2012) Mapping the brain in type II diabetes: Voxel-based morphometry using DARTEL. Euro J Radiol 81:1870-1876.
12. Cheng G, Huang C, Deng H, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 42:484-491.
13. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R (2005) Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 64:1704-1711.
14. Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ (2012) An update on type 2 diabetes, vascular dementia and Alzheimer’s disease. Exp Gerontol 47:858-864.
15. Gianaros PJ, Greer PJ, Ryan CM, Jennings JR (2006) Higher blood pressure predicts lower regional grey matter volume: Consequences on short-term information processing. Neuroimage 31:754-765.
16. Gold SM, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H, Tsui W, Richardson S, Javier E, Convit A (2007) Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50:711-719.
17. Guerchet M, Aboyans V, Nubukpo P, Lacroix P, Clement JP, Preux PM (2011) Ankle-brachial index as a marker of cognitive impairment and dementia in general population. A systematic review. Atherosclerosis 216:251-257.
18. Kamiyama K, Wada A, Sugihara M, Kurioka S, Hayashi K, Hayashi T, Yoshisako T, Yamamoto N, Tsuchie Y, Yamaguchi S, Sugimoto T, Kitagaki H (2010) Potential hippocampal region atrophy in diabetes mellitus type 2: a voxel-based morphometry VSRAD study. Jpn J Radiol 28:266-272.
19. Korf ES, White LR, Scheltens P, Launer LJ (2006) Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care 29:2268-2274.
20. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191-2192.
21. Maldjian JA, Laurienti PJ, Burdette JH (2004) Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 21:450-455.
22. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19:1233-1239.
23. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ, Utrecht Diabetic Encephalopathy Study G (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55:1106-1113.
24. Manschot SM, Biessels GJ, de Valk H, Algra A, Rutten GE, van der Grond J, Kappelle LJ, Utrecht Diabetic Encephalopathy Study G (2007) Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 50:2388-2397.
25. Mazoyer B, Zago L, Mellet E, Bricogne S, Etard O, Houde O, Crivello F, Joliot M, Petit L, Tzourio-Mazoyer N (2001) Cortical networks for working memory and executive functions sustain the conscious resting state in man. Brain Res Bull 54:287-298.
26. McCrimmon RJ, Ryan CM, Frier BM (2012) Diabetes and cognitive dysfunction. Lancet 379:2291-2299.
27. Mendez MF, Ala T, Underwood KL (1992) Development of scoring criteria for the clock drawing task in Alzheimer’s disease. J Am Geriatr Soc 40:1095-1099.
28. Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, Munch G, Wood AG, Forbes J, Greenaway TM, Pearson S, Srikanth V (2013) Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 36:4036-4042.
29. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM, Jimerson DC, Hennen J, Renshaw PF, Jacobson AM (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326-333.
30. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1-266.
31. Paula JJ, Miranda DM, Moraes EN, Malloy-Diniz LF (2013) Mapping the clockworks: what does the Clock Drawing Test assess in normal and pathological aging? Arq Neuropsiquiatr 71:763-768.
32. Perantie DC, Wu J, Koller JM, Lim A, Warren SL, Black KJ, Sadler M, White NH, Hershey T (2007) Regional brain volume differences associated with hyperglycemia and severe hypoglycemia in youth with type 1 diabetes. Diabetes Care 30:2331-2337.
33. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, Hofman A, Breteler MM (2005) Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128:2034-2041.
34. Rafnsson SB, Deary IJ, Fowkes FG (2009) Peripheral arterial disease and cognitive function. Vasc Med 14:51-61.
35. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001) A default mode of brain function. Proc Natl Acad Sci U S A 98:676-682.
36. Shulman GL, Fiez JA, Corbetta M, Buckner RL, Miezin FM, Raichle ME, Petersen SE (1997) Common Blood Flow Changes across Visual Tasks: II. Decreases in Cerebral Cortex. J Cogn Neurosci 9:648-663.
37. Vagelatos NT, Eslick GD (2013) Type 2 diabetes as a risk factor for Alzheimer’s disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev [Epub ahead of print].
38. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2008) Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39:2712-2719.
39. van Harten B, Oosterman JM, Potter van Loon BJ, Scheltens P, Weinstein HC (2007a) Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 57:70-74.
40. van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein HC (2007b) Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 36:164-170.
41. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32:1318-1322.
42. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495.
43. Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ, Rombouts SA (2006) Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49:2474-2480.
44. Zhou H, Lu W, Shi Y, Bai F, Chang J, Yuan Y, Teng G, Zhang Z (2010) Impairments in cognition and resting-state connectivity of the hippocampus in elderly subjects with type 2 diabetes. Neurosci Lett 473:5-10.